Trueblood Wealth Management’s Boston Scientific BSX Stock Holding History

Trueblood Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,612	Closed	-$440K	–	258
2025 Q4	$440K	Buy	4,612 +2	+0%	+$196	0.17%	163
2025 Q3	$450K	Buy	4,610 +281	+6%	+$29.1K	0.18%	161
2025 Q2	$465K	Buy	4,329 +8	+0.2%	+$809	0.19%	151
2025 Q1	$436K	Buy	4,321 +1,191	+38%	+$120K	0.2%	141
2024 Q4	$280K	Buy	3,130 +5	+0.2%	+$440	0.14%	188
2024 Q3	$262K	Buy	3,125 +393	+14%	+$31K	0.13%	191
2024 Q2	$210K	Buy	+2,732	New	+$200K	0.12%	208

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Trueblood Wealth Management's BSX Position: Q1 2026 in Review

Trueblood Wealth Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 4,612 shares — an estimated $440K sold.

Trueblood Wealth Management first reported a position in BSX in Q2 2024 and held it in 7 quarters. The position peaked at $465K in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Trueblood Wealth Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Trueblood Wealth Management sold 4,612 Boston Scientific shares in Q1 2026, an estimated $440K.
Trueblood Wealth Management first reported a position in Boston Scientific in Q2 2024 and held it in 7 quarters.
Trueblood Wealth Management's Boston Scientific position peaked at $465K in Q2 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Trueblood Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.